ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,428, issued on Jan. 13, was assigned to INSTITUT PASTEUR (Paris).

"Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host" was invented by Rogerio Amino (Bagneux, France), Pierre Charneau (Paris), Catherine Blanc (Chantilly, France) and Vanessa Lagal (Fontenay sous Bois, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to chimeric Plasmodium antigenic polypeptides derived from pre-erythrocytic (PE) antigens and associated in a fusion polypeptide. In particular, the invention relates to antigenic fusion polypeptides of malaria parasites wherein sa...